Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
07/2012
07/26/2012WO2012099453A1 Pyrrolothiazole containing curcumin compounds
07/26/2012WO2012099452A1 Curcumin compounds with superior structural stability and processes for their preparation
07/26/2012WO2012099451A1 Curcumin compounds containing indolizine and their preparations thereof
07/26/2012WO2012099375A2 P47phox or p67phox-targeting therapeutic agent for stress disorders, and method for screening for same
07/26/2012WO2012099260A1 Orally dispersible tablet
07/26/2012WO2012099200A1 Pyrazole derivative
07/26/2012WO2012098645A1 Method for production of model animal for mental diseases
07/26/2012WO2012098546A2 Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
07/26/2012WO2012098461A1 Fused aminodihydrothiazine derivatives
07/26/2012WO2012098387A1 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors
07/26/2012WO2012098213A1 Fused aminodihydrothiazine derivatives useful as bace inhibitors
07/26/2012WO2012098070A1 Quinoline dyrk1 inhibitors
07/26/2012WO2012098068A1 Pyrazolo pyrimidines as dyrk1a and dyrk1b inhibitors
07/26/2012WO2012097869A1 Derivatives of nicotinic acid n-oxide, their preparation and their use as inhibitors of enzyme 3-hydroxyanthranilate-3,4-dioxygenase
07/26/2012WO2012075492A3 Carbocycle-substituted purine and 7-deazapurine compounds
07/26/2012WO2012065182A3 Modulation of ubiquitination of synaptic proteins for the treatment of neurodegenerative and psychiatric disorders
07/26/2012WO2012052169A3 Particulate pharmaceutical composition containing an opioid and an opioid antagonist
07/26/2012WO2012050404A3 Composition containing ginseng and having nicotine removal effect
07/26/2012WO2012050402A3 Cell-permeable recombinant parkin protein and a pharmaceutical composition for treating degenerative brain diseases containing the same
07/26/2012WO2012048129A3 Inhibitors of polo-like kinase
07/26/2012US20120192294 Inhibitors of the Nitration of Amyloid Beta Peptides and Their Uses in the Diagnosis and Treatment of Alzheimer's Disease
07/26/2012US20120191039 Carrier linked pramipexole prodrugs
07/26/2012US20120190861 Levodopa Prodrugs, and Compositions and Uses Thereof
07/26/2012US20120190752 Exo-s-mecamylamine method, use, and compound for treatment
07/26/2012US20120190751 Compounds for treatments of inflammation
07/26/2012US20120190743 Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity
07/26/2012US20120190741 Compounds for inhibition of 5-hydroxytryptamine and norepinephrine reuptake or for treatment of depression disorders, their preparation processes and uses thereof
07/26/2012US20120190737 Fatty Acid Formulations and Methods of Use Thereof
07/26/2012US20120190728 Compositions and methods for modulation of smn2 splicing in a subject
07/26/2012US20120190725 Inhibitor(s) of transporters or uptake of monoaminergic neurotransmitters
07/26/2012US20120190721 Method for treating nervous system disorders and conditions
07/26/2012US20120190719 Methods of treating motor disorders with alpha-2b andrenergic receptor agonists
07/26/2012US20120190716 Methods and uses of cytochrome p450 inhibitors
07/26/2012US20120190712 Methods for Treating Cognitive Disorders
07/26/2012US20120190710 Bicyclo-heptan-2-amines
07/26/2012US20120190707 Selective inhibitors of akt and methods of using same
07/26/2012US20120190706 Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof
07/26/2012US20120190704 Azaadamantane ester and carbamate derivatives and methods of use thereof
07/26/2012US20120190701 Renin inhibitors
07/26/2012US20120190692 Selective substituted pyridine ligands for neuronal nicotinic receptors
07/26/2012US20120190689 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist
07/26/2012US20120190686 Bicyclo[3.2.1]octyl amide derivatives and uses of same
07/26/2012US20120190685 Novel phenylimidazole derivative as pde10a enzyme inhibitor
07/26/2012US20120190682 Modulators for amyloid beta
07/26/2012US20120190680 Heteroaryl Amide Analogues
07/26/2012US20120190674 Sulfonamides as trpm8 modulators
07/26/2012US20120190672 Fused aminodihydrothiazine derivatives
07/26/2012US20120190670 Transnasal Anticonvulsive Pharmaceutical Composition Comprising Poorly Soluble Anticonvulsant
07/26/2012US20120190652 Diagnostic agent for parkinson's disease
07/26/2012US20120190651 Anti-inflammatory compounds
07/26/2012US20120190650 Inhibitors of Autotaxin
07/26/2012US20120190649 Bicyclic aryl sphingosine 1-phosphate analogs
07/26/2012US20120190648 Fluorinated cyclopropane analogs of glutamic acid
07/26/2012US20120190634 Lipoteichoic acid-derived glycolipids, and compositions comprising same
07/26/2012US20120190626 Amyloid beta fibrillogenesis-inhibiting peptide
07/26/2012US20120190616 Analogues of Insulin-Like Growth Factor-1 (IGF-1) Having Amino Acid Substitution at Position 59
07/26/2012US20120189723 Herbal composition for reducing add/adhd and method thereof
07/26/2012US20120189720 Method for treatment of diarrhea-predominant irritable bowel syndrome
07/26/2012US20120189705 Pharmaceutical Compositions
07/26/2012US20120189703 Enzyme Delivery Systems and Methods of Preparation and Use
07/26/2012US20120189697 Compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine
07/26/2012US20120189695 Pharmaceutical dosage form
07/26/2012US20120189693 Oral dosage forms
07/26/2012US20120189688 Carrier component and fabrication method thereof
07/26/2012US20120189679 Method for coating powders
07/26/2012US20120189667 Method for repairing or replacing damaged tissue
07/26/2012US20120189642 Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
07/26/2012US20120189638 Method of treating neurodegenerative disease
07/26/2012US20120189626 Treatment of complement-associated disorders
07/26/2012US20120189624 Treatment and prophylaxis of amyloidosis
07/26/2012US20120189619 Methods for treating a spinal disorder or osteoarthritis using dominant negative tissue necrosis factor
07/26/2012US20120189615 CROSS-ß STRUCTURE COMPRISING AMYLOID-BINDING PROTEINS AND METHODS FOR DETECTION OF THE CROSS-ß STRUCTURE, FOR MODULATING CROSS-ß STRUCTURES FIBER FORMATION AND FOR MODULATING CROSS-ß STRUCTURE-MEDIATED TOXICITY
07/26/2012US20120189614 Inhibitors of filovirus entry into host cells
07/26/2012US20120189613 Stim2-mediated capacitive calcium entry
07/26/2012US20120189610 Treatment of pain
07/26/2012US20120189600 Compositions and methods for treating neurodegenerative diseases
07/26/2012US20120189583 Placental or umbilical cord tissue compositions
07/26/2012US20120189575 Oligodendrocyte Production from Multipotent Neural Stem Cells
07/26/2012US20120189558 Anti-bacterial compositions comprising extracts of eremophila longifolia and methods for use of same
07/26/2012US20120189541 Dual Variable Domain Immunnoglobulins and Uses Thereof
07/26/2012CA2828738A1 Fused aminodihydrothiazine derivatives useful as bace inhibitors
07/26/2012CA2825273A1 Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
07/26/2012CA2824900A1 Treatment of cognitive dysfunction in schizophrenia
07/26/2012CA2824430A1 Orally dispersible tablet
07/26/2012CA2823955A1 Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-ht6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
07/26/2012CA2823675A1 Fused aminodihydrothiazine derivatives
07/25/2012EP2479183A2 Polymorphs of sarsasapogenin
07/25/2012EP2479168A1 6-Substituted 2,3,4,5-Tetrahydro-1H-Benzo [d]Azepines as 5-HT2C Receptor Agonists
07/25/2012EP2478918A2 Compositions and methods for the treatment of addiction and other neuropsychiatric disorders
07/25/2012EP2478917A1 SP35 antibodies and uses thereof
07/25/2012EP2478903A1 Compositions comprising activators of PKC and inhibitors of PKC ubiquitination
07/25/2012EP2478901A2 Neurogenic compounds
07/25/2012EP2478099A1 Method and composition for treating alzheimer-type dementia
07/25/2012EP2478002A2 Small peptide modulators of potassium channel trafficking
07/25/2012EP2477994A1 Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, preparation and use thereof
07/25/2012EP2477988A1 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof
07/25/2012EP2477974A2 Nicotine haptens, immunoconjugates and their uses
07/25/2012EP2477963A1 Aryl sulphone derivatives as calcium channel blockers
07/25/2012EP2477960A1 Crystalline modifications of 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol
07/25/2012EP2477656A1 Treatment of neurological conditions
1 ... 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 ... 1833